US biomedical innovation leadership at risk: New data show China rapidly closing gap as clinical trials and manufacturing migrate abroad
Meeting Announcement
The United States still leads China in the quality and commercial reach of its biomedical science but is losing the race to translate scientific discoveries into cures. New analyses from the Cure Innovation Index, released today ahead of Cure's session on U.S.-China biomedical competitiveness at the BIO International Convention in San Diego, find that without immediate renewed investment and policy changes, the U.S. scientific edge will not hold. “America’s challenge is no longer discovery alone. The emerging battleground is translation, the speed and efficiency with which scientific breakthroughs move from the laboratory into development, commercialization, and patient impact," said Seema Kumar, CEO of Cure, the premier healthcare innovation ecosystem headquartered in New York City. If the United States wants to stay ahead, the answer isn't to out-publish China. It's to fix the translational bottlenecks with renewed funding, especially for early translational work, modernized clinical trial infrastructure, and stronger bridges between academic research and industry.
Led by Dr. Alex Zhavoronkov, Founder, CEO, and CBO of Insilico Medicine, the Insilico Medicine team will meet with biopharma partners, investors, and researchers at Booth #4021 to explore collaboration opportunities. Insilico Medicine will showcase the core capabilities of its end-to-end Pharma.AI platform as well as its latest R&D pipeline.
Winterthur, 10 June 2026 – The roads, railways, and waterways that Europe uses to transport goods and people are deeply interconnected. But they often behave as separate systems. The EU-funded MOVEO project wants to find better ways to integrate these systems to make transport safer, more efficient and more reliable.
The third annual Cleveland Discovery and Innovation Forum, hosted by Cleveland Clinic and IBM, highlighted progress in applying quantum computing and AI to healthcare and life sciences research. The forum brought together global leaders in healthcare, science and technology to share insights into how advanced computing is accelerating discovery and shaping the future of patient care.
The one-day event, held today on Cleveland Clinic’s Main Campus, featured more than 30 speakers from academia, industry, foundations, venture capital and government.